A Study of Erlotinib (Tarceva) in Participants With Resected Head and Neck Squamous Cell Cancer

Clinical trial NCT00412217 · TERMINATED

Trial details

NCT number: NCT00412217
Sponsor: Hoffmann-La Roche
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Head and Neck Cancer

Start date: 2006-11-01
Primary completion: 2009-12-01
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.